Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gerburg Wulf, M.D.

Concepts (475)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Gerburg Wulf's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Gerburg Wulf has written about over time.
Peptidylprolyl Isomerase, 24 publications between 1999 and 2020, average publication date February 2006. Cell Transformation, Neoplastic, 9 publications between 2002 and 2016, average publication date June 2008. Breast, 7 publications between 2001 and 2024, average publication date December 2011. Breast Neoplasms, 38 publications between 2001 and 2024, average publication date October 2015. Genes, BRCA1, 3 publications between 2011 and 2023, average publication date October 2015. Mammary Neoplasms, Experimental, 6 publications between 2006 and 2024, average publication date November 2015. Infectious Mononucleosis, 2 publications between 2012 and 2022, average publication date June 2017. BRCA1 Protein, 10 publications between 2009 and 2022, average publication date November 2017. Poly(ADP-ribose) Polymerases, 3 publications between 2012 and 2024, average publication date January 2018. Phosphatidylinositol 3-Kinases, 9 publications between 2011 and 2024, average publication date April 2019. Ovarian Neoplasms, 6 publications between 2016 and 2022, average publication date April 2019. Phthalazines, 7 publications between 2017 and 2022, average publication date April 2020.

To see the data from this visualization as text, click here.
Wulf's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (475)
Explore
_
Co-Authors (89)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.